EVQLV Media
EVQLV Welcomes Operations & Finance Lead Alexander Sonneborn
EVQLV Submits 1 Million Ab Initio Derived Sequences for Validation
Fully Automated Rabbit Humanization Project Initiated w/ U Buffalo
EVQLV Accepted to Prestigious Techstars Boston Accelerator
EVQLV Welcomes Chief Scientific Officer Richard Fox
EVQLV Joins Endless Frontier Labs Incubator
EVQLV, Manhattan BioSolutions Enter Strategic Collaboration to Discover Novel Antibody Therapies
The collaboration fuses EVQLV’s expertise in AI-enabled antibody design & Manhattan BioSolutions’ expertise in antibody development in oncology
EVQLV CEO’s Article Published in ‘Life Science Leader’
Examining AI as automated, assistive, analytical, accelerated, or augmented intelligence is a framework for thinking about how to apply these tools to data in ways that are aligned with an organization’s goals. This framework is designed to allow those who do not routinely build or employ AI to avoid the overhyped rhetoric of AI and consider the practical outcomes of employing it.
Andrew Satz on the ‘Amplifying Scientific Innovation’ Podcast with Dr. Sophia Ononye-Onyia
EVQLV CEO, Andrew Satz, recently joined the Amplifying Scientific Innovation podcast with Dr. Sophia Ononye-Onyia. They discussed his definition of scientific innovation, personal anecdotes of his CEO journey and EVQLV’s unique approach to scientific innovation through the acceleration of biologic therapies with the power of artificial intelligence (A.I.).
How Our Algorithm Models the Drug Discovery Process
Our CEO, Andrew Satz, recently spoked at “Alumni in Conversation,” hosted by Columbia University School of General Studies. During the discussion, Andrew explained how EVQLV’s algorithm models the drug discovery process.
Large Pharma’s Embrace of Artificial Intelligence
The benefits of computational drug development are well known and accepted by many in the pharmaceutical space. However, since the onset of the global pandemic, consensus went from it being an interesting concept that was almost certainly the future, to something we need implemented as soon as possible. This is one of the few silver linings of the coronavirus outbreak.